 | • レポートコード：MRC2102QY7009 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の免疫チェックポイントエージェント市場について種類別（抗PD-L1薬、抗PD-1薬、CTLA4）、用途別（肺がん、結腸直腸がん、乳がん、前立腺がん、黒色腫、血液がん）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・免疫チェックポイントエージェント市場の概要 ・世界の主要地域別免疫チェックポイントエージェント市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の免疫チェックポイントエージェント市場規模2015-2026：種類別（抗PD-L1薬、抗PD-1薬、CTLA4） ・世界の免疫チェックポイントエージェント市場規模2015-2026：用途別（肺がん、結腸直腸がん、乳がん、前立腺がん、黒色腫、血液がん） ・免疫チェックポイントエージェントの米国市場規模2015-2020 ・免疫チェックポイントエージェントのヨーロッパ市場規模2015-2020 ・免疫チェックポイントエージェントの中国市場規模2015-2020 ・免疫チェックポイントエージェントの日本市場規模2015-2020 ・免疫チェックポイントエージェントの東南アジア市場規模2015-2020 ・免疫チェックポイントエージェントのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・免疫チェックポイントエージェントの製造コスト分析 ・販売チャネル、流通業者、顧客 ・免疫チェックポイントエージェントの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Immune Checkpoint Agents Market
The global Immune Checkpoint Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Immune Checkpoint Agents Scope and Market Size
The global Immune Checkpoint Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immune Checkpoint Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Immune Checkpoint Agents market is segmented into
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
Segment by Application, the Immune Checkpoint Agents market is segmented into
Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers
The Immune Checkpoint Agents market is analysed and market size information is provided by regions (countries). Segment by Application, the Immune Checkpoint Agents market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immune Checkpoint Agents Market Share Analysis
Immune Checkpoint Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immune Checkpoint Agents business, the date to enter into the Immune Checkpoint Agents market, Immune Checkpoint Agents product introduction, recent developments, etc.
The major vendors covered:
Bristol Myers Squibb
Merck
AstraZeneca
Roche
1 Immune Checkpoint Agents Market Overview
1.1 Immune Checkpoint Agents Product Scope
1.2 Immune Checkpoint Agents Segment by Type
1.2.1 Global Immune Checkpoint Agents Sales by Type (2020-2026)
1.2.2 Anti-PD-L1 Drug
1.2.3 Anti-PD-1 Drug
1.2.4 CTLA4
1.3 Immune Checkpoint Agents Segment by Application
1.3.1 Global Immune Checkpoint Agents Sales Comparison by Application (2020-2026)
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 BreastCancer
1.3.5 Prostate Cancer
1.3.6 Melanoma
1.3.7 Blood Cancers
1.4 Immune Checkpoint Agents Market Estimates and Forecasts (2015-2026)
1.4.1 Global Immune Checkpoint Agents Sales Growth Rate (2015-2026)
1.4.2 Global Immune Checkpoint Agents Revenue and Growth Rate (2015-2026)
1.4.3 Global Immune Checkpoint Agents Price Trends (2015-2026)
2 Immune Checkpoint Agents Estimate and Forecast by Region
2.1 Global Immune Checkpoint Agents Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Immune Checkpoint Agents Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Immune Checkpoint Agents Sales Market Share by Region (2015-2020)
2.2.2 Global Immune Checkpoint Agents Revenue Market Share by Region (2015-2020)
2.3 Global Immune Checkpoint Agents Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Immune Checkpoint Agents Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Immune Checkpoint Agents Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Immune Checkpoint Agents Estimates and Projections (2015-2026)
2.4.2 Europe Immune Checkpoint Agents Estimates and Projections (2015-2026)
2.4.3 China Immune Checkpoint Agents Estimates and Projections (2015-2026)
2.4.4 Japan Immune Checkpoint Agents Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Immune Checkpoint Agents Estimates and Projections (2015-2026)
2.4.6 India Immune Checkpoint Agents Estimates and Projections (2015-2026)
3 Global Immune Checkpoint Agents Competition Landscape by Players
3.1 Global Top Immune Checkpoint Agents Players by Sales (2015-2020)
3.2 Global Top Immune Checkpoint Agents Players by Revenue (2015-2020)
3.3 Global Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Agents as of 2019)
3.4 Global Immune Checkpoint Agents Average Price by Company (2015-2020)
3.5 Manufacturers Immune Checkpoint Agents Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Immune Checkpoint Agents Players (Opinion Leaders)
4 Global Immune Checkpoint Agents Market Size by Type
4.1 Global Immune Checkpoint Agents Historic Market Review by Type (2015-2020)
4.1.1 Global Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
4.1.2 Global Immune Checkpoint Agents Revenue Market Share by Type (2015-2020)
4.1.3 Global Immune Checkpoint Agents Price by Type (2015-2020)
4.2 Global Immune Checkpoint Agents Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Immune Checkpoint Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Immune Checkpoint Agents Revenue Forecast by Type (2021-2026)
4.2.3 Global Immune Checkpoint Agents Price Forecast by Type (2021-2026)
5 Global Immune Checkpoint Agents Market Size by Application
5.1 Global Immune Checkpoint Agents Historic Market Review by Application (2015-2020)
5.1.1 Global Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
5.1.2 Global Immune Checkpoint Agents Revenue Market Share by Application (2015-2020)
5.1.3 Global Immune Checkpoint Agents Price by Application (2015-2020)
5.2 Global Immune Checkpoint Agents Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Immune Checkpoint Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Immune Checkpoint Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Immune Checkpoint Agents Price Forecast by Application (2021-2026)
6 United States Immune Checkpoint Agents Market Facts & Figures
6.1 United States Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
6.2 United States Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
6.3 United States Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
7 Europe Immune Checkpoint Agents Market Facts & Figures
7.1 Europe Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
7.2 Europe Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
7.3 Europe Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
8 China Immune Checkpoint Agents Market Facts & Figures
8.1 China Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
8.2 China Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
8.3 China Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
9 Japan Immune Checkpoint Agents Market Facts & Figures
9.1 Japan Immune Checkpoint Agents Sales Market Share by Company (3015-3030)
9.2 Japan Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
9.3 Japan Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
10 Southeast Asia Immune Checkpoint Agents Market Facts & Figures
10.1 Southeast Asia Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
11 India Immune Checkpoint Agents Market Facts & Figures
11.1 India Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
11.2 India Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
11.3 India Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Immune Checkpoint Agents Business
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Corporation Information
12.1.2 Bristol Myers Squibb Business Overview
12.1.3 Bristol Myers Squibb Immune Checkpoint Agents Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bristol Myers Squibb Immune Checkpoint Agents Products Offered
12.1.5 Bristol Myers Squibb Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Immune Checkpoint Agents Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Immune Checkpoint Agents Products Offered
12.2.5 Merck Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Business Overview
12.3.3 AstraZeneca Immune Checkpoint Agents Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Immune Checkpoint Agents Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Business Overview
12.4.3 Roche Immune Checkpoint Agents Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Roche Immune Checkpoint Agents Products Offered
12.4.5 Roche Recent Development
…
13 Immune Checkpoint Agents Manufacturing Cost Analysis
13.1 Immune Checkpoint Agents Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immune Checkpoint Agents
13.4 Immune Checkpoint Agents Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immune Checkpoint Agents Distributors List
14.3 Immune Checkpoint Agents Customers
15 Market Dynamics
15.1 Immune Checkpoint Agents Market Trends
15.2 Immune Checkpoint Agents Opportunities and Drivers
15.3 Immune Checkpoint Agents Market Challenges
15.4 Immune Checkpoint Agents Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Immune Checkpoint Agents Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Immune Checkpoint Agents Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Immune Checkpoint Agents Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Immune Checkpoint Agents Sales (K Units) by Region (2015-2020)
Table 5. Global Immune Checkpoint Agents Sales Market Share by Region (2015-2020)
Table 6. Global Immune Checkpoint Agents Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Immune Checkpoint Agents Revenue Share by Region (2015-2020)
Table 8. Global Immune Checkpoint Agents Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Immune Checkpoint Agents Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Immune Checkpoint Agents Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Immune Checkpoint Agents Revenue Share Forecast by Region (2021-2026)
Table 12. Global Immune Checkpoint Agents (K Units) of Key Companies (2015-2020)
Table 13. Global Immune Checkpoint Agents Sales Share by Company (2015-2020)
Table 14. Global Immune Checkpoint Agents Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Immune Checkpoint Agents Revenue Share by Company (2015-2020)
Table 16. Global Immune Checkpoint Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Checkpoint Agents as of 2019)
Table 17. Global Immune Checkpoint Agents Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Immune Checkpoint Agents Manufacturing Sites and Area Served
Table 19. Manufacturers Immune Checkpoint Agents Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Immune Checkpoint Agents Players
Table 22. Global Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 23. Global Immune Checkpoint Agents Sales Share by Type (2015-2020)
Table 24. Global Immune Checkpoint Agents Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Immune Checkpoint Agents Price (K Units) by Type (2015-2020)
Table 26. Global Immune Checkpoint Agents Sales Share by Type (2021-2026)
Table 27. Global Immune Checkpoint Agents Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Immune Checkpoint Agents Revenue Share by Type (2021-2026)
Table 29. Global Immune Checkpoint Agents Price (K Units) by Type (2021-2026)
Table 30. Global Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 31. Global Immune Checkpoint Agents Sales Share by Application (2015-2020)
Table 32. Global Immune Checkpoint Agents Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Immune Checkpoint Agents Price (K Units) by Application (2015-2020)
Table 34. Global Immune Checkpoint Agents Sales (K Units) by Application (2021-2026)
Table 35. Global Immune Checkpoint Agents Sales Share by Application (2021-2026)
Table 36. Global Immune Checkpoint Agents Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Immune Checkpoint Agents Revenue Share by Application (2021-2026)
Table 38. Global Immune Checkpoint Agents Price (K Units) by Application (2021-2026)
Table 39. United States Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 40. United States Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 41. United States Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 42. United States Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 43. United States Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 44. United States Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
Table 45. Europe Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 46. Europe Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 47. Europe Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 48. Europe Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 49. Europe Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 50. Europe Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 51. China Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 52. China Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 53. China Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 54. China Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 55. China Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 56. China Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
Table 57. Japan Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 58. Japan Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 59. Japan Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 60. Japan Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 61. Japan Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 62. Japan Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
Table 69. India Immune Checkpoint Agents Sales (K Units) by Company (2015-2020)
Table 70. India Immune Checkpoint Agents Sales Market Share by Company (2015-2020)
Table 71. India Immune Checkpoint Agents Sales (K Units) by Type (2015-2020)
Table 72. India Immune Checkpoint Agents Sales Market Share by Type (2015-2020)
Table 73. India Immune Checkpoint Agents Sales (K Units) by Application (2015-2020)
Table 74. India Immune Checkpoint Agents Sales Market Share by Application (2015-2020)
Table 75. Bristol Myers Squibb Corporation Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb Immune Checkpoint Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bristol Myers Squibb Immune Checkpoint Agents Product
Table 79. Bristol Myers Squibb Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Immune Checkpoint Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Immune Checkpoint Agents Product
Table 84. Merck Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Immune Checkpoint Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Immune Checkpoint Agents Product
Table 89. AstraZeneca Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Immune Checkpoint Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Roche Immune Checkpoint Agents Product
Table 94. Roche Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Immune Checkpoint Agents Distributors List
Table 98. Immune Checkpoint Agents Customers List
Table 99. Immune Checkpoint Agents Market Key Trends
Table 100. Immune Checkpoint Agents Key Opportunities and Drivers
Table 101. Immune Checkpoint Agents Market Challenges
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Immune Checkpoint Agents Product Picture
Figure 2. Global Immune Checkpoint Agents Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Immune Checkpoint Agents Market Share by Application in 2020 & 2026
Figure 6. Lung Cancer Examples
Figure 7. Colorectal Cancer Examples
Figure 8. BreastCancer Examples
Figure 9. Prostate Cancer Examples
Figure 10. Melanoma Examples
Figure 11. Blood Cancers Examples
Figure 12. Global Immune Checkpoint Agents Sales (K Units) Growth Rate (2015-2026)
Figure 13. Global Immune Checkpoint Agents Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Immune Checkpoint Agents Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 15. Global Immune Checkpoint Agents Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Immune Checkpoint Agents Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Immune Checkpoint Agents Sales (K Units) Growth Rate (2015-2026)
Figure 19. Europe Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Immune Checkpoint Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Immune Checkpoint Agents Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Immune Checkpoint Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Immune Checkpoint Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Immune Checkpoint Agents Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Immune Checkpoint Agents Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Immune Checkpoint Agents Players Market Share by Revenue in Immune Checkpoint Agents 2015 & 2019
Figure 30. Immune Checkpoint Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Immune Checkpoint Agents Revenue Share by Type (2015-2020)
Figure 32. Global Immune Checkpoint Agents Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Immune Checkpoint Agents Revenue Share by Application (2015-2020)
Figure 34. Global Immune Checkpoint Agents Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 36. United States Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 37. Europe Immune Checkpoint Agents Sales Market Share by Company in 2019
Figure 38. Europe Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 39. Europe Immune Checkpoint Agents Sales Market Share by Application in 2019
Figure 40. China Immune Checkpoint Agents Sales Market Share by Company in 2019
Figure 41. China Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 42. China Immune Checkpoint Agents Sales Market Share by Application in 2019
Figure 43. Japan Immune Checkpoint Agents Sales Market Share by Company in 2019
Figure 44. Japan Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 45. Japan Immune Checkpoint Agents Sales Market Share by Application in 2019
Figure 46. Southeast Asia Immune Checkpoint Agents Sales Market Share by Company in 2019
Figure 47. Southeast Asia Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 48. Southeast Asia Immune Checkpoint Agents Sales Market Share by Application in 2019
Figure 49. India Immune Checkpoint Agents Sales Market Share by Company in 2019
Figure 50. India Immune Checkpoint Agents Sales Market Share by Type in 2019
Figure 51. India Immune Checkpoint Agents Sales Market Share by Application in 2019
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Immune Checkpoint Agents
Figure 54. Manufacturing Process Analysis of Immune Checkpoint Agents
Figure 55. Immune Checkpoint Agents Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
免疫チェックポイント阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Immune Checkpoint Blockers Market The global Immune Checkpoint Blockers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Immune Checkpoint Blockers Scope and Market Size The global Im…- 免疫健康補助食品の世界市場レポート2020 Immune Health Supplements refer to the product which could improve human immune health. Market competition is intense. Amway, Bayer AG, INFINITUS, PERFECT (CHINA), Swisse, GNC, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Market Analysis …
- 移行防止剤の世界市場レポート2020 Market Analysis and Insights: Global Anti Migrating Agents Market The global Anti Migrating Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti Migrating Agents Scope and Market Size The global Anti Migrating Ag…
- アスファルト剥離防止剤の世界市場レポート2020 Anti-stripping agents are often overlooked when boosting the performance of asphalt. It is added to asphalt to increase the occurrence and strength of asphalt-aggregate adhesion The technical barriers of Asphalt Anti-Stripping Agents are relatively high, resulting in high level concentration degree.…
- 再付着防止剤の世界市場レポート2020 Market Analysis and Insights: Global Anti-redeposition Agents Market The global Anti-redeposition Agents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti-redeposition Agents Scope and Market Size The global Anti-red…